The FDA has granted priority review to a Biologics License Application for nipocalimab to treat individuals with generalized myasthenia gravis who are antibody positive, according to the manufacturer.

NEW YORK, NY / ACCESSWIRE / January 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf ...

Johnson & Johnson stock (NYSE: JNJ) lost about 7% in 2024, underperforming the broader S&P 500 index, which gained 23% for ...

Johnson & Johnson JNJ announced that the FDA has accepted its regulatory filing seeking the FDA’s approval for nipocalimab, ...

The 13-year veteran has 1,838 combined tackles in his career, which is fourth all time behind Ray Lewis, London Fletcher and ...

Kroger will pay Kentucky $110 million in settlement funds that will ultimately go to combat the opioid crisis Kentucky Attorney General Russell Coleman says the business helped fuel.

With two years remaining on his contract and carrying a $4.5 million cap hit, the Leafs would need to navigate salary cap ...

After being listed as probable coming into tonight's game vs the Suns, the Atlanta Hawks have officially revealed Trae ...

CLEMSON, S.C. — On the back of a season-high 28-point performance from Kymora Johnson, Virginia (10-6, 2-2 ACC) defeated Clemson (10-6, 3-2 ACC) 67-60 on Thursday night (Jan. 9) at Littlejohn Coliseum ...

The New England Patriots announced Friday that they completed an interview with Mike Vrabel for their open head coaching ...

PHILADELPHIA - The playoffs aren’t guaranteed for any NFL team, though the Eagles have had a nice run of postseason trips ...

As of Thursday, the Chicago Bears have interviewed two high-profile candidates for the open head coaching position. The Bears ...